Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"NFkB2"”.
-
p100 abundance as a regulator of T and B cell development
… Our group identified a novel mutation in NFKB2 in a patient with complete deficiency of mature B cells, antibody deficiency, alopecia, and recurrent infections. More than 50 patients have now been described with this syndrome, although immune deficiency and autoimmunity vary in severity …
-
Alternative Nf-kb Signaling in Atherogenesis
… lesion development in a knockout mouse model. Nfkb2 knockout (Nfkb2-/-) mice were generated on two different atherosclerosis sensible backgrounds, the Apoe- and Ldlr- deficient background. Quantification of atherosclerotic lesion development showed, that Nfkb2-/- mice developed significantly …
-
The control of inflammation in airway epithelial cells
… protein NFKB1 following poly(I:C) stimulation, NFKB2 protein expression was suppressed. In contrast to Pellino-1 knockdown, the transient knockdown of NFKB2 resulted in significant increase in CXCL8 mRNA and protein expression and in turn did not regulate Pellino-1 mRNA expression to poly(I:C). …
-
Mutationen in Genen von Proteinen der Apoptose und deren Einfluss auf den Krankheitsverlauf und das Therapieansprechen bei Patienten mit chronischer Hepatitis C
… bekannte SNPs in den Genen für FAS, IL-4, IL-6, NFKB2, NFKB1A, NFKBIL1, MAPK13 und MAPK14 mit Hilfe der TagMan Untersuchung genotypisiert. Ergebnis: Der heterozygote Genotyp IL4 -589 (C/T) ist signifikant (p=0,0498) mit einem sustained virological response (SVR) bei Patienten, die mit PegIFN-α …
-
Molecular and cellular regulation of human TH9 cell differentiation
… LOF mutations in IRF4, STAT5B, ITK, NFKB1, NFKB2, MAGT1, STAT3, STAT1, IFNGR1, IL12RB1, TBX21, IL27R, IL6ST, IRAK4 or IL10R, GOF mutations in STAT3 or STAT1, as well as Down syndrome patients with an extra copy of genes encoding IFNGR2, IFNAR1 and IFNAR2, to differentiate into IL-9 producing …
-
Understanding Molecular Mechanisms of Striated Muscle Laminopathies Using Cellular and Zebrafish Models
… to their swim impairment. Expression of jun and nfkb2 was decreased while activated Erk 1/2 was increased in mutants. Jun, NF-KB and Erk 1/2 are biomarkers for striated muscle laminopathies. Furthermore, activation of Pkc α, an upstream Erk 1/2 regulator, was increased in the lmna mutants …
-
COUP-TFII and its interacting proteins in breast cancer and endocrine resistance.
… between COUP-TFII and IL6, ICAMl, TNFAIP3, NFKB2, REL, RELA, and RELB was observed in breast tumors from tamoxifen-treated breast cancer patients. The combination of COUP-TFII overexpression, NFK13 inhibition, and tamoxifen treatment inhibited the growth of endocrine-resistant breast cancer …
-
Análise de expressão gênica da via de sinalização do receptor do fator de crescimento semelhante à insulina tipo 1 no câncer de endométrio
… MAP2K2, MAPK3, MEF2C, MEF2D, NFATC2, NFATC3. NFKB2, NFKBIA, NRAS, PDPK1, PIK3CD, PIK3R1, PIK3R2, PLCG1, PPP3CA, PPP3R1, PRKCI, RAF1, RAPGEF1, RELA, RPS6, RPS6KB1, SOS1, YWHAB, YWHAE, YWHAH e YWHAQ, um não apresentou expressão em nenhum dos grupos (SLC2A4) e não foi possível analisar os …
-
Caratterizzazione molecolare della sindrome di Sezary e possibili risvolti prognostico-terapeutici.
… of patients, 10q25.1 in 65%, 10q24 (involving NFkB2 gene) in 63%, and 19p13.3 (involving the cell growth/apoptosis regulating GADD45B gene) in 40%. With regard to chromosome 17, we observed loss of region 17p13.1 (containing the TP53 gene) in 75% of cases, whereas a gain in 17q21 (harbouring …
-
Genomics of human pituitary neuroendocrine tumours
… by srWGS but identified by lrWGS such as <em>NFKB2</em> and <em>IDH2</em>.</p> <br> <p>For structural variant analysis in PitNETs, I report finding SV changes to the genes <em>ATM, ATRX, FGFR</em> gene family, <em>GNAS</em> and <em>RAF1</em>. The downstream annotation findings from srWGS were …
-
Investigation of Gain-of-Function Induced by Mutant p53
p53 is mutated in 50% of all human cancers, and up to 70% of lung cancer. Mutant p53 is usually expressed at elevated levels in cancer cells and has been correlated with a poor prognosis. Cancer cells that express mutant p53 show an increase in oncogenic phenotypes including an increase in growth …